The FDA has provided clearance for Siemens SOMATOM portfolio of CT scanners for low-dose lung cancer screening.
The U.S. FDA has cleared the SOMATOM CT systems by Siemens Healthcare for low-dose lung cancer screening, Siemens announced last week.
All of Siemens new CT scanners, as well as the company’s installed base of non-end-of-support systems use standard low-dose lung protocols already delivered on the scanners, Siemens said in a release. Automated settings in the Siemens’ portfolio, like reducing user variability, and setting an optimum range for scan settings that avoids cut-offs or excessive radiation, optimize the low-dose lung cancer screening workflow, Siemens said.
Siemens has also launched a mobile imaging solution for lung cancer screening aimed for people living in rural areas, the company announced. The mobile SOMATOM Scope CT is a self-powered mobile CT with an on-board diesel generator that is ready to scan “within minutes” of parking and is equipped with a high-speed wireless connection, Siemens said.
The indication for low-dose lung cancer screening is available for the following CT systems: SOMATOM Force, SOMATOM Definition Flash, SOMATOM Definition Edge, SOMATOM Definition AS/AS+, SOMATOM Perspective, SOMATOM Scope, and the SOMATOM Emotion 16.
[[{"type":"media","view_mode":"media_crop","fid":"43954","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_4646017352372","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4885","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Image provided courtesy of Siemens Healthcare.","typeof":"foaf:Image"}}]]
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.